申请人:KYOWA HAKKO KOGYO KABUSHIKI KAISHA
公开号:EP0667349A1
公开(公告)日:1995-08-16
A depression remedy containing a triazine derivative represented by general formula (I) or a pharmacologically acceptable salt thereof as the active ingredient, wherein R1 represents hydrogen, (un)substituted lower alkyl or (un)substituted lower alkanoyl; R2 represents hydrogen, (un)substituted lower alkyl, (un)substituted lower alkenyl, (un)substituted cycloalkyl, (un)substituted aryl, (un)substituted aralkyl or (un)substituted heterocycle; R3 represents (un)substituted heterocycle; X represents a single bond, O, S, S(O), S(O)2 or NR4, wherein R4 represents hydrogen or (un)substituted lower alkyl or R2 and NR4 are combined with each other to form a 4- to 6-membered (un)substituted nitrogeneous saturated heterocyclic group; and A represents N or CR5, wherein R5 represents hydrogen or (un)substituted lower alkyl.
一种抑郁症药物,含有通式(I)代表的三嗪衍生物或其药理上可接受的盐作为活性成分,其中R1代表氢、(未)取代的低级烷基或(未)取代的低级烷酰基;R2代表氢、(未)取代的低级烷基、(未)取代的低级烯基、(未)取代的环烷基、(未)取代的芳基、(未)取代的芳烷基或(未)取代的杂环;R3 代表(未)取代的杂环; X 代表单键、O、S、S(O)、S(O)2 或 NR4,其中 R4 代表氢或(未)取代的低级烷基或 R2 和 NR4 相互结合形成 4 至 6 元(未)取代的硝基饱和杂环基团;以及 A 代表 N 或 CR5,其中 R5 代表氢或(未)取代的低级烷基。